The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia: A Prospective Randomized Multicenter Trial.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Alfuzosin; Celecoxib; Doxazosin; Tamsulosin; Terazosin
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 10 Jun 2013 Biomarkers information updated
- 01 Mar 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 12 Dec 2011 Planned end date changed from 1 Oct 2009 to 1 Jun 2012 as reported by ClinicalTrials.gov.